Phosphodiesterase-5 (PDE-5) Inhibition in Heart Transplant Recipients

Mise à jour : Il y a 4 ans
Référence : NCT01812434

Femme et Homme

Extrait

Hypothesis 1: Treatment of heart transplant recipients with sildenafil, a PDE-5 inhibitor, will improve small artery elasticity (SAE) when compared to placebo. Hypothesis 2: PDE-5 inhibition will improve endothelial function, resulting in increased production of nitric oxide, reduced activation of circulating endothelial cells, and increased endothelial progenitor cells.


Critère d'inclusion

  • Cardiac Allograft Vasculopathy

Liens